Glympse Bio is developing a powerful new paradigm in diagnostics designed to enable earlier, noninvasive detection and monitoring of disease. The company’s technology uses proprietary nanoparticles that interrogate the body for certain disease states and then carry the message to the urine for analysis.
- Sangeeta Bhatia, MD, PhD Founder
- Gabe Kwong, PhD Founder & President
- Eric Huang, PhD Chief Development Officer
- Andrew Warren, PhD Founding Scientist & Product Development Lead
- Sophie Cazanave, PhD Senior Scientist